Mezagitamab
Mezagitamab Uses, Dosage, Side Effects, Food Interaction and all others data.
Mezagitamab is under investigation in clinical trial NCT04278924 (Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Persistent/chronic Primary Immune Thrombocytopenia).
| Trade Name | Mezagitamab |
| Generic | Mezagitamab |
| Mezagitamab Other Names | Mezagitamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Mezagitamab
